Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.77 |
| ▸ | MAPT | P10636 | 9/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | RAB9A | P51151 | 1/20 | 0.69 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 4/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | TLR2 | O60603 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17816985 | 0.96 | ALDH1A1 (0.77) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3646473 | 0.88 | KDM4E (0.76) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3648831 | 0.87 | KDM4E (0.78) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL8288688 | 0.87 | ALDH1A1 (0.91) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL6437345 | 0.85 | ALDH1A1 (0.68) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL8288672 | 0.85 | ALDH1A1 (0.93) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL14542539 | 0.85 | ALDH1A1 (0.74) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL24104916 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3125764 | 0.83 | ALDH1A1 (0.88) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A | |
| SCHEMBL8288697 | 0.82 | ALDH1A1 (0.86) | ALDH1A1KDM4EMAPTSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3229811-B1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GRI BIO INC (US) | 2021-02-24 | — | — | EP | disclosed |
| WO-2016094226-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GLYCOREGIMMUNE, INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| US-20160158258-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | ALTIUM GROWTH FUND, LP | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160158258-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | RXRA, RXRG, CX3CR1 | ALDH1A1 999/4885KDM4E 812/4885MAPT 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.